June 2025

Catheters recalled over safety concerns | 'Landmark' imaging document | AI models make an impact | High-tech pants for MRI scans ()
Polymer valve impresses | Heart surgeon salaries for men vs. women | CEPD use during TAVR fails to improve outcomes ()
Week in Review: Procedure kits recalled | FDA requires new warnings | J&J MedTech's legal battle continues | New TAVR tech ()
Heart attack deaths are way down—other risks have skyrocketed | Private equity & heart failure | New leadership ()
FDA finalizes new heart warnings | The impact of anti-DEI policies | Heart attack deaths are down | AI restores subpar MRI scans ()
Popular obesity drugs & PAD | TTVR linked to positive real-world outcomes | New report raises questions about FDA, AstraZeneca ()
Private equity's influence | J&J MedTech faces new threat in antitrust case | Lilly makes a move | Tariffs & the device market ()
A historic heart transplant | First-in-human data on new TAVR tech | HFSA's next leaders | On-the-go risk evaluations ()
ASNC, AMA fight AI use to deny prior authorizations | FDA recall of bypass cannula | First patient gets HF LV reducer ()
AFib ablation during CABG | Cardiologists are first in world to use cooling device | A new 2D ICE catheter launches ()
Support grows for early use of obesity meds | J&J MedTech faces new threat after losing case | 'Landmark' CT guidance ()
Week in Review: EARLY TAVR concerns | An update from Medtronic | Unqualified cardiologist linked to deaths | 2 major recalls ()
FDA clears blood clot removal system for PE | Catheters recalled | Tiny clot-busting robots | Stroke care keeps evolving ()
A new Class I recall for catheters | Push for an independent board gains an ally | The many risks of cannabis use | TAVR & TR ()
Marijuana use & blood vessel damage | More than 2 million CGM receivers recalled | Soda, fruit juice increase diabetes risk ()
CGM receivers recalled over safety issues | AI for nongated CT scans | Medtronic tech at center of new training center ()
Heart surgeons make history | Unpacking major trends & changes | Progress for polymer valves | Real-world data on SAVR vs. TAVR ()
Lilly inks deal worth up to $1.3B | Women need new CVD guidelines | Atraverse Medical raises $29M | New York Valves 2025 ()
The top 25 heart hospitals in the United States | Tiny clot-busting robots | Long wait times | Robotic TAVR explant & AVR ()
FDA OKs blood clot tech for PE | Pushing for better healthcare policies | Do physicians need business training? | New TAVR data ()
Q&A: EARLY TAVR co-author questions study | 'Fraudulent’ cardiologist linked to deaths | Medtronic diabetes spin-off gets a name ()
Top 10 most popular cardiology video interviews this past month ()
Week in Review: An expensive decision | RDN eligibility | FDA approves 3-in-1 polypill | A new recall | ACC backs AMA resolution ()
A new recall for GE HealthCare | Imaging pioneer remembered for his joy & enthusiasm | The potential harms of tariffs ()
J&J MedTech told to pay $442M | ASNC speaks to Congress | FDA wants more heart warnings on vaccines | Private equity's influence ()
Private equity & heart failure | AMA to fight for payment changes | Meditation linked to ‘real, lasting benefits’ ()
IVL delivers value for women | Cardiologist paralyzed after decades in cath lab | Robotic PCI safe & effective | New TTVR tech ()
FDA approves polypill for hypertension | High-tech pants could improve stress tests | Balloon-expandable vs. self-expanding TAVR ()
AMA resolution looks to boost lung screening with calcium scoring | 35 million eligible for renal denervation | First laser IVL ()
The first robotic heart surgeries of their kind | FDA approves self-expanding TMVR device | PPMI & mitral valve surgery ()
Confirmed: AFib ablation during CABG improves survival | Johnson & Johnson MedTech must now pay $442M | ASNC speaks to Congress ()
Week in Review: The top 25 US heart hospitals | Doctor paralyzed after decades in cath lab | Heart surgeons make history | More ()
News Alert: Judge triples damages in lawsuit, ordering Johnson & Johnson MedTech to pay $442M ()
The first robotic surgery of its kind | Polymer heart valve gains key approval | A closer look at GE HealthCare's new CT scanner ()
TAVR Highlights: A big approval for Medtronic | Boston Scientific pulls the plug | Same-day discharge linked to key benefits ()
Doctor paralyzed after decades in the cath lab | Clot-busting robots could transform care | Real-world data favor SAVR over TAVR ()
FDA approves AI-enabled wearable cardioverter defibrillator | Predicting LBBB risk before TAVR | Real-time blood clot monitoring ()
Inflammation playing a key role in heart evaluations | Contrast in the cath lab | PE-backed cardiology group makes a deal ()
May's Top Stories: Big news from Boston Scientific | PFA & heart damage | First TAVR valves approved for asymptomatic patients ()
The top 25 US heart hospitals | Outcomes in urban vs. rural areas | TAVR protocol boosts care | Why soda is so 'problematic' ()
Robotic imaging system used for first time | CCTA shows colchicine's impact | Imaging for chest pain | CT-guided PCI ()
FDA sees promise in total artificial heart tech | Why surgery trials need more diversity | New-look peripheral stent approved ()